Targeted Therapies Plus Chemotherapy Provide Path Around Acquired Resistance in AML
OncLive,
Targeted therapies, specifically those agents directed at mutated proteins and aberrant protein-to-protein interactions, have…
Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib
Overview of attention for article published in Blood, December 2018
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
High Attention Score compared to outputs of the same age and source (93rd percentile)
Mentioned by
- news
- 1 news outlet
- policy
- 1 policy source
- 21 X users
- patent
- 13 patents
- 1 Facebook page
Readers on
- mendeley
- 223 Mendeley